Vanishing white matter disease, a rare leukodystrophy with mutation in the EIF2B5 gene

被引:0
|
作者
Sinko, Gabriella [1 ]
Tompa, Marton [2 ,3 ]
Kiss, Zsuzsanna [4 ]
Kalman, Bernadette [2 ,5 ]
机构
[1] Markusovszky Univ, Dept Pediat, Teaching Hosp, Szombathely, Hungary
[2] Markusovszky Univ, Teaching Hosp, Ctr Mol Med, Szombathely, Hungary
[3] Szentagotha Res Ctr, Hungarian Ctr Genom & Bioinformat, Pecs, Hungary
[4] Markusovszky Univ, Dept Lab Med, Div Clin Genet, Teaching Hosp, Szombathely, Hungary
[5] Univ Pecs, Sch Med, Dept Lab Med, Pecs, Hungary
来源
关键词
vanishing white matter disease; whole exome sequencing; RATING-SCALE; HYPERINTENSITIES; MRI; DEMENTIA;
D O I
10.18071/isz.77.0207
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background - Leukodystrophies, a hete roge neous group of brain and spinal cord dis orders, often pose challenges in es tab li shing molecular etiology. Vanishing White Matter Disease (VWMD) is a rare sub type of leu kodys trophies presenting with characteristic clinical and MRI features, ne ver theless, achieving diag nostic certainty requires genetic studies. Case presentation - Our patient is a nine year old girl, who developed progressive gait difficulties at around 3-4 years of age. Her brain MRI showed confluent lesions with increased signal intensity in the cerebral and cerebellar white matter on T2/FLAIR se quen ces, within which hypointense regions ap peared with signal intensity resembling that of the cerebrospinal fluid on T1 sequences. Whole exome sequencing identified a homozygous likely pathogenic variant within the EIF2B5 gene in the proband, which was present in a heterozygous state in both asymptomatic parents. Having the clinical and molecular genetic diagnosis established, we explored therapeutic possibilities for the patient. Conclusion - VWMD is a severe form of leukodystrophies with little or no disease modifying therapy available until recently. A better understanding of its molecular pathogenesis offers some hope for new inventive therapies.
引用
收藏
页数:69
相关论文
共 50 条
  • [1] Vanishing White Matter Disease with Mutations in EIF2B5 Gene
    Sharma, Suvasini
    Ajij, Mohemmed
    Singh, Varinder
    Aneja, Satinder
    INDIAN JOURNAL OF PEDIATRICS, 2015, 82 (01): : 93 - 95
  • [2] Vanishing White Matter Disease with Mutations in EIF2B5 Gene
    Suvasini Sharma
    Mohemmed Ajij
    Varinder Singh
    Satinder Aneja
    The Indian Journal of Pediatrics, 2015, 82 : 93 - 95
  • [3] Peripheral neuropathy in vanishing white matter disease with a novel EIF2B5 mutation
    Federico, A.
    Scali, O.
    Stromillo, M. L.
    Di Perri, C.
    Bianchi, S.
    Sicurelli, F.
    De Stefano, N.
    Malandrini, A.
    Dotti, M. T.
    NEUROLOGY, 2006, 67 (02) : 353 - 355
  • [4] Peripheral neuropathy in a case of vanishing white matter disease with a novel EIF2B5 mutation
    Di Perri, C
    Garnbelli, S
    Berti, G
    Scali, O
    Stromillo, ML
    Bianchi, S
    Sicurelli, F
    De Stefano, N
    Malandrini, A
    Dotti, MT
    Federico, A
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2006, 11 (02) : 187 - 187
  • [5] EIF2B5 mutations compromise GFAP+ astrocyte generation in vanishing white matter leukodystrophy
    Dietrich, J
    Lacagnina, M
    Gass, D
    Richfield, E
    Mayer-Pröschel, M
    Noble, M
    Torres, C
    Pröschel, C
    NATURE MEDICINE, 2005, 11 (03) : 277 - 283
  • [6] EIF2B5 mutations compromise GFAP+ astrocyte generation in vanishing white matter leukodystrophy
    Jörg Dietrich
    Michelle Lacagnina
    David Gass
    Eric Richfield
    Margot Mayer-Pröschel
    Mark Noble
    Carlos Torres
    Christoph Pröschel
    Nature Medicine, 2005, 11 : 277 - 283
  • [7] Adult-onset leukoencephalopathy with vanishing white matter with a missense mutation in EIF2B5
    Ohtake, H
    Shimohata, T
    Terajima, K
    Kimura, T
    Jo, R
    Kaseda, R
    Iizuka, O
    Takano, M
    Akaiwa, Y
    Goto, H
    Kobayashi, H
    Sugai, T
    Muratake, T
    Hosoki, T
    Shioiri, T
    Okamoto, K
    Onodera, O
    Tanaka, K
    Someya, T
    Nakada, T
    Tsuji, S
    NEUROLOGY, 2004, 62 (09) : 1601 - 1603
  • [8] Vanishing white matter disease with a novel EIF2B5 mutation: A 10-year follow-up
    Bektas, Gonca
    Yesil, Gozde
    Ozkan, Melis Ulak
    Yildiz, Edibe Pembegul
    Uzunhan, Tugce Aksu
    Caliskan, Mine
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2018, 171 : 190 - 193
  • [9] Late-onset vanishing white matter disease with compound heterozygous EIF2B5 gene mutations
    Lee, H. -N.
    Koh, S. -H.
    Lee, K. -Y.
    Ki, C. -S.
    Lee, Y. J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 (03) : e42 - e43
  • [10] Leukoencephalopathy with vanishing white matter: Clinicopathological characteristics of a rare adult-onset case with a homozygous EIF2B5 mutation
    Seike, Naohiko
    Shimizu, Hiroshi
    Tanaka, Koh
    Ikeuchi, Takeshi
    Tanaka, Masaharu
    Takahashi, Hitoshi
    Kakita, Akiyoshi
    BRAIN PATHOLOGY, 2019, 29 : 97 - 97